Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Fitusiran | Hemophilia | HongKong DengYue Medicine
FDA Approves Fitusiran (QFITLIA) to Prevent or Reduce the Frequency of ...
Fitusiran | SIELC Technologies
他山之石-7丨siRNA 药物 Fitusiran 上市历程及临床开发路径总结 - 知乎
Antithrombin-lowering in hemophilia: a closer look at fitusiran ...
Fitusiran | C78H139N11O30 | CID 119058042 - PubChem
Fitusiran Approved for Hemophilia A and B | MedPage Today
WO2023240199A2 - Treatment of hemophilia with fitusiran - Google Patents
Sanofi's fitusiran earns orphan drug designation for hemophilia in Korea
Fitusiran Substantially Reduces Hemophilia Bleeds with Simple Monthly ...
Fitusiran Antithrombin-Based Regimen Ensures Effective Bleed Control in ...
Long-term safety and efficacy of fitusiran prophylaxis, and ...
FDA Approves Fitusiran as Prophylaxis of Bleeding Episodes Due to ...
Fitusiran prophylaxis in people with hemophilia A or B who switched ...
WO2022120292A1 - Treatment of hemophilia with fitusiran - Google Patents
FDA Approves Fitusiran for Reducing Bleeds in Patients With Hemophilia A/B
Fitusiran Is a Drug to Watch in the Hematology Space in 2025
Fitusiran Monograph for Professionals - Drugs.com
#VisualAbstract: Once-a-month fitusiran reduces bleeding rates in ...
Fitusiran prophylaxis ‘great option’ for reducing bleeds in people with ...
Global dosing hold in fitusiran trials initiated by Sanofi Genzyme to ...
Fitusiran « New Drug Approvals
DailyMed - QFITLIA- fitusiran injection, solution
Study of Fitusiran for Preventing Bleeding in Boys Aged 1 to 12 with ...
Study on Fitusiran for Preventing Bleeding in Males Aged 12 and Older ...
FDA Approves Fitusiran For Prophylactic Hemophilia A, B Treatment ...
Fitusiran May Open Doors for Treatment of Multiple Women’s Bleeding ...
Pharmacokinetic Characteristics of Fitusiran in Plasma after ...
Phase 3 Studies Lead to Approval of Fitusiran for Hemophilia A and B ...
Fitusiran Approved for People With Hemophilia A or B, With and Without ...
Fitusiran Maintains Long-Term Bleeding Control in Hemophilia A or B ...
FDA Approves Fitusiran for Treatment of Hemophilia A and B | CheckRare
Fitusiran Shows Promise as Prophylactic Therapy for Hemophilia A, B
Fitusiran aprobado por la FDA para hemofilia A y B
Resumption of Hemophilia Therapy Fitusiran Trials Get FDA Blessing ...
Fitusiran prophylaxis in people with severe haemophilia A or ...
Insights into the mechanism of action of fitusiran & the value of this ...
FDA Approves Sanofi’s siRNA Therapy Fitusiran for the Treatment of ...
QFITLIA® (fitusiran) | For US HCPs
FDA Approves Qfitlia for Hemophilia A & B With/Without Inhibitors
Full article: RNAi for the Treatment of People with Hemophilia: Current ...
A Molecular Revolution in the Treatment of Hemophilia: Molecular Therapy
QFITLIA® (fitusiran) Mechanism of Action | For US HCPs
Qfitlia (fitusiran) for hemophilia | Hemophilia News Today
FDA Approves Qfitlia (Fitusiran): Groundbreaking siRNA Therapy for ...
Qfitlia (fitusiran): Side Effects, Uses, Dosage, Interactions, Warnings
Start Hemophilia Treatment with HemAssist | Sanofi HemAssist
Factor Xa | 凝血因子 Xa | 抑制剂 | MCE
想重点关注Fitusiran通过RNA干扰减少抗凝血酶表达实际的情况_行行查_行业研究数据库
Qfitlia approved as the first therapy in the US to treat hemophilia A ...
网上展厅
Alnylam Pharmaceuticals Press Release | Mar 28, 2025 | FDA Approves ...
Fitusiran: A Game-Changing Drug for Hemophilia Patients
Qfitlia(fitusiran)治疗血友病A/B中文说明书-价格-适应症-不良反应及注意事项-香港济民药业
#healthcare #hospital #pharmacology #medical #research #pharmacy… | Dr ...
2024.11.18-11.24官方法规及动态
JAN: Japanese Accepted Names for Pharmaceuticals
FDA Approves Qfitlia™ (fitusiran), the First siRNA (RNAi Therapeutic ...
每月一针：赛诺菲血友病siRNA疗法申报上市 Armstrong 2024年5月7日，赛诺菲Fitusiran注射液的上市申请获得NMPA受理 ...
全球首款A/B型血友病siRNA疗法3期数据亮眼，每月仅需1次给药
Gene silencing | PPTX
Normal Saline Intravenous (Iv) Infusion Solutions Bulk Manufacturers ...
Fitusiran's Efficacy in Hemophilia Prophylaxis | PDF | Coagulation ...
Redefining Hemophilia Management: Treatment Goals, Nonfactor ...
How to find the chemical modification of fitusiran?
芬妥司兰钠(Fitusiran) - 药物靶点：AT III_在研适应症：血友病A，血友病B，出血_专利_临床_研发
菲图西兰（Fitusiran）--Qfitlia说明书_药得
